Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Jan 07, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-25-000043.pdf
0001714899-25-000043.rtf
0001714899-25-000043.xls
Jan 07, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-25-000041.pdf
0001714899-25-000041.rtf
Jan 07, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-25-000045.pdf
0001714899-25-000045.rtf
0001714899-25-000045.xls
Jan 07, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001714899-25-000047.pdf
0001714899-25-000047.rtf
Jan 03, 2025 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-25-000001.pdf
0001714899-25-000001.rtf
0001714899-25-000001.xls
Jan 03, 2025 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-25-000002.pdf
0001714899-25-000002.rtf
0001714899-25-000002.xls
Jan 02, 2025 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-25-000045.pdf
0001950047-25-000045.rtf
0001950047-25-000045.xls
Dec 31, 2024 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
0001950047-24-010114.pdf
0001950047-24-010114.rtf
Dec 31, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000236.pdf
0001714899-24-000236.rtf
0001714899-24-000236.xls
Nov 27, 2024 4 Statement of changes in beneficial ownership of securities View HTML
0001714899-24-000235.pdf
0001714899-24-000235.rtf
0001714899-24-000235.xls
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • …
  • Next page ›
  • Last page »
Displaying 41 - 50 of 710 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use